Cefoperazone was compared with penicillin against Streptococcus pneumoniae, gentamicin against Escherichia coli, and ampicillin and chloramphenicol against Haemophilus influenzae in the therapy of experimental meningitis in rabbits. Meningitis was produced by intracistemal inoculation into cerebrospinal fluid, and all antibiotics were administered intravenously over 8 h in dosages that would achieve serum levels comparable to those found in humans. The mean percent penetration into purulent cerebrospinal fluid, expressed as (cerebrospinal fluid concentration/serum concentration) x 100%o, was 2.6% for penicillin, 22.0% for gentamicin, 12.1% for ampicillin, 23.8% for chloramphenicol, and 6.4% for cefoperazone. The mean cerebrospinal fluid antibiotic concentrations exceeded the minimum bactericidal concentration for the test strain in each experimental model, except for ampicillin in experimental meningitis due to the P-lactamaseproducing H. influenzae. Cefoperazone produced a significantly faster bactericidal effect after 4 h of treatment when compared with penicillin (P = 0.037) and ampicillin (P = 0.01) in meningitis caused by S. pneumoniae and H. influenzae (ampicillin susceptible), respectively. In meningitis caused by E. coli, cefoperazone was significantly (P = 0.006) more rapidly bactericidal after 8 h of treatment when compared to gentamicin. In addition, cefoperazone was significantly more rapidly bactericidal than either ampicillin or chloramphenicol in experimental meningitis due to P-lactamase-producing H. influenzae. Cefoperazone deserves further evaluation in the therapy of bacterial meningitis in humans.
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The recent emergence of penicillin-or chloramphenicol-resistant pneumococci (13) , ampicillin-or chloramphenicol-resistant H. influenzae (7, 22) , and the poor therapeutic results with aminoglycosides in gram-negative bacillary meningitis (17, 18) make it important to develop new antimicrobial agents in the therapy of these infections. Cefoperazone, with its high activity against the above organisms, including 1-lactamase-positive H. influenzae and aminoglycoside-resistant Enterobacteriaceae (3, 8, 10, 12, 14, 15, 16, 19) , and its capacity to cross the inflamed meninges (20, 23 Preparation of inocula. These procedures have been described in detail previously (9, 29) . The final inocula (in colony-forming units (CFU), final volume, 0.15 to 0.3 ml) were as follows: pneumococci -10, E. coli 10S5, H. influenzae = 108 5.
Induction of menIngtis. Two-kilogram New Zealand white rabbits were prepared with modifications as described previously (9, 25) . A dental acrylic helmet was attached to the animals' skulls, which allowed rigid immobilization in a stereotaxic frame. A Assessment of therapeutic results. Serial blood (3 ml) and CSF (0.2 ml) samples were taken from an indwelling femoral arterial catheter and spinal needle, respectively, before treatment and after 4 and 8 h of therapy. Each CSF sample was titered immediately for quantitative bacterial counts. Serial dilutions were performed and added to tryptic soy agar pour plates with 0.5 ml of sheep blood added for S. pneumoniae counts. For H. influenzae, CSF samples were surface plated on chocolate agar (with IsoVitaleX added). All of the remaining CSF and serum samples were kept at -70°u ntil antibiotic assays were performed (within 2 weeks). This period of storage did not affect the assay results. In addition, antibiotic concentrations were determined on serum and CSF samples drawn 1 and 2 h after initiation of treatment (for a total of five determinations per animal).
Antibiotic assays. Antibiotic levels were determined by agar well diffusion techniques. Bacillus subtilis spore solution (0.9 ml) was added to 1,000 ml of antibiotic medium no. 1 (Difco) and no. 11 for the penicillin and ampicillin assays, respectively. Gentamicin concentrations were assayed with a multidrugresistant strain of Staphylococcus epidermidis (ATCC 27626) by the technique described by Alcid and Seligman (1) . Chloramphenicol bioassays employed a marine bacterium (Beneckea natriegens) in 1.5% salt agar as described previously (4). The cefoperazone assay used 2.5 ml of a suspension containing Sarcina lutea (ATCC 9341) in antibiotic medium no. 1. This suspension gave a transmission of 21% at 580 nm. All specimens and standards were tested in triplicate. Wells (4 mm) were cut into the agar and filled with approximately 0.03 ml of specimen. The zone of inhibition was measured (after 18 h of incubation at 37°C) and compared to a standard curve. The standard curve was determined by dissolving known concentrations of antibiotic in pooled rabbit serum and saline (zone sizes for identical concentrations of antibiotic dissolved in rabbit CSF and saline were found to be equal). Thus, all CSF concentrations were calculated from standards that used saline diluent.
Statisical procedures used in data analysis. The percent penetration of drug into the CSF is defined by the formula: percent penetration = (CSF concentration/serum concentration) x 100%. Statistical analysis for change in CSF bacterial concentrations was done on unpaired data by Student's t test (two tailed). The degree of CSF sterilization between drugs was compared by Fisher's exact test. In addition, covariance and regression line analysis were performed to assess differences between drugs in each model.
RESULTS
Penetration of antibiotics into CSF. Table 1 shows the mean serum and CSF antibiotic concentration obtained and the percent penetration into the CSF for the agents used in this study. In each case, steady-state serum and CSF levels were obtained within 1 h of initiating infusions. Ampicillin and penicillin (which were given at a dose of 30 mg/kg per h) achieved mean serum levels of 31.9 and 17.0 ,ug/ml, respectively. Gentamicin, delivered at 2.5 mg/kg per h, gave a mean serum level of 11.5 jig/ml over the 8-h period. The mean serum level of chloramphenicol, delivered at 30 mg/kg per h, was 27.2 ,ug/ml. The mean serum level of cefoperazone was much higher than that obtained with the other agents, 148 ,ug/ml, but it was given at a higher dosage (60 mg/kg per h). These levels are similar to those found in humans after standard parenteral therapy. The CSF antibiotic levels reflect the concurrent serum levels and the ability of the drug to penetrate across the inflamed meninges (Table 1 ). The mean CSF drug concentration exceeded the minimum bactericidal concentra-VOL. 22, 1982 on October 26, 2017 by guest http://aac.asm.org/ Downloaded from It can be seen in Table 2 (significant differences are indicated) that cefoperazone achieved a significantly more rapid bactericidal effect in vivo than the accepted agent(s) in each model of meningitis employed in these studies. In some infections (e.g., pneumococcal-or ampicilhinsensitive H. influenzae meningitis), the differences between cefoperazone and the reference agent were apparent after 4 h of therapy but the results were similar and not significantly different after the full 8-h treatment interval. In other models (e.g., E. coli meningitis; Table 2 ), the re,verse was seen, whereas in experimental ampicillin-resistant H. infiuenzae meningitis, cefoperazone was more rapidly bactericidal than ampiciflin or chloramphenicol at both time points analyzed.
Sterilization of the CSF was analyzed for each drug after 4 and 8 h of treatment ( (11) , this may decrease the in vivo efficacy of cefoperazone, and caution on the use of cefoperazone is advised until more experience accumulates on the treatment of these infections. However, cefoperazone was rapidly bactericidal in our studies, despite CSF bacteria counts of 2107 CFU/ml in 11 of 22 animals. In addition to the favorable in vitro activity and in vivo efficacy of cefoperazone noted above, the pharmacokinetics of this new agent are an important consideration. The serum halflife of cefoperazone is longer than cefamandole in both rabbits and humans (26, 27) . More importantly, the major route of elimination is biliary; no adjustments in dosage are necessary for renal insufficiency (6), a common occurrence in seriously ill patients, including those with meningitis.
Cefoperazone (and other new P-lactam agents) deserves further evaluation for use against bacterial meningitis in humans.
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